ストックスクリーナーアプリを入手
4.915
22.48%
-1.425
プレマーケット:
5.10
0.185
+3.76%
前日終値:
$6.34
開ける：
$5.62
24時間の取引高:
2.22M
Relative Volume:
4.31
時価総額：
$92.23M
収益：
$109.43M
当期純損益:
$5.13M
株価収益率:
18.86
EPS:
0.2606
ネットキャッシュフロー:
$18.91M
1週間 パフォーマンス:
-24.03%
1か月 パフォーマンス:
-17.12%
6か月 パフォーマンス:
-68.21%
1年 パフォーマンス:
-55.36%
1日の値動き範囲:
$4.57
$5.72
1週間の範囲:
$4.57
$6.77
52週間の値動き範囲:
$4.57
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Compare OPRX vs VEEV, BTSG, TEM, HQY, DOCS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
4.915 | 118.97M | 109.43M | 5.13M | 18.91M | 0.2606 |
VEEV
Veeva Systems Inc
|
155.73 | 26.02B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
56.50 | 10.76B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
45.90 | 8.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
82.18 | 6.80B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
23.39 | 4.89B | 637.78M | 239.40M | 307.21M | 1.1909 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-08 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-07-25 | 再開されました | B. Riley Securities | Buy |
| 2024-04-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-02-02 | 再開されました | B. Riley Securities | Buy |
| 2022-11-01 | 開始されました | Stifel | Buy |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2021-10-18 | 再開されました | B. Riley Securities | Buy |
| 2021-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2019-01-03 | 開始されました | William Blair | Outperform |
すべてを表示
Optimizerx Corp (OPRX) 最新ニュース
OptimizeRx (NASDAQ: OPRX) cuts Q1 loss as margins improve and debt refinanced - Stock Titan
B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating - marketscreener.com
Stifel cuts OptimizeRx stock price target on weaker guidance By Investing.com - Investing.com Australia
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript - Insider Monkey
OPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OptimizeRx Q1 Earnings Call Highlights - sharewise.com
Earnings Call Summary | OptimizeRx(OPRX.US) Q1 2026 Earnings Conference - Moomoo
OptimizeRx Corp. (OPRX) surpasses Q1 earnings and revenue estimates - MSN
Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises - Investing.com
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.13, revenue topped estimates - Investing.com
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
OptimizeRx Secures New Credit Facility to Boost Flexibility - TipRanks
OPTIMIZERX ($OPRX) Releases Q1 2026 Earnings - Quiver Quantitative
OptimizeRx (Nasdaq: OPRX) posts Q1 2026 results and secures $35M credit facility - Stock Titan
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - The Manila Times
Press Release: OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - Moomoo
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - Zacks Investment Research
OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - Markets Mojo
Pharma ads go programmatic inside doctors' EHRs via OptimizeRx - Stock Titan
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
OptimizeRx Corp expected to post breakeven results a shareEarnings Preview - TradingView
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings? - The Globe and Mail
MSN Money - MSN
OptimizeRx (NASDAQ:OPRX) Lowered to "Hold" Rating by Zacks Research - MarketBeat
Earnings preview: OptimizeRx Corp. (OPRX) Q1 earnings expected to decline - MSN
OptimizeRx (OPRX) Projected to Post Earnings on Tuesday - MarketBeat
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline - sharewise.com
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - Yahoo Finance
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[ARS] OptimizeRx Corp SEC Filing - Stock Titan
OptimizeRx (OPRX) sets 2026 virtual meeting, equity plan expansion and pay votes - Stock Titan
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report - marketscreener.com
OptimizeRx ESG report counts supply-chain emissions for first time - Stock Titan
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4: 30 p.m. ET - marketscreener.com
OptimizeRx will post quarterly results before a May 12 investor call - Stock Titan
OPRX OptimizeRx Corporation posts 120.6 percent Q4 2025 EPS surprise, shares rise modestly in today’s trading. - Newser
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy? - TradingView
JMP Securities Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - TradingView
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
New OptimizeRx Corp (OPRX) director registers insider status with Form 3 - Stock Titan
Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds? - Yahoo Finance
Optimizerx Corp (OPRX) 財務データ
収益
当期純利益
現金流量
EPS
6.05%
1.65%
大文字化:
|
ボリューム (24 時間):